Wolverine Trading, LLC Spectrum Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.32 - $0.52 $7,008 - $11,388	-21,900 Reduced 39.96%	32,900 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $18,189 - $65,988	42,300 Added 338.4%	54,800 $25,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.4 $700 - $1,400	-1,000 Reduced 7.41%	12,500 $10,000
Q1 2022 May 16, 2022	BUY	$0.63 - $1.59 $1,953 - $4,929	3,100 Added 29.81%	13,500 $17,000
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.82 $32,250 - $57,300	-15,000 Reduced 59.06%	10,400 $23,000
Q2 2021 Aug 06, 2021	SELL	$2.89 - $4.45 $9,537 - $14,685	-3,300 Reduced 11.5%	25,400 $99,000
Q1 2021 May 14, 2021	BUY	$2.9 - $4.09 $35,960 - $50,716	12,400 Added 76.07%	28,700 $88,000
Q4 2020 Feb 12, 2021	SELL	$3.38 - $5.14 $9,126 - $13,878	-2,700 Reduced 14.21%	16,300 $59,000
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $11,362 - $18,620	3,800 Added 25.0%	19,000 $79,000
Q2 2020 Aug 13, 2020	SELL	$2.11 - $3.38 $422 - $676	-200 Reduced 1.3%	15,200 $47,000
Q1 2020 May 11, 2020	SELL	$1.83 - $3.45 $51,240 - $96,600	-28,000 Reduced 64.52%	15,400 $35,000
Q4 2019 Feb 12, 2020	BUY	$3.5 - $10.35 $96,600 - $285,660	27,600 Added 174.68%	43,400 $155,000
Q3 2019 Nov 14, 2019	BUY	$7.03 - $9.7 $111,074 - $153,260	15,800 New	15,800 $140,000
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $664,104 - $997,764	-40,200 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $646,818 - $927,414	40,200 New	40,200 $647,000
Q4 2017 Feb 14, 2018	SELL	$13.36 - $20.73 $597,192 - $926,631	-44,700 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$8.75 - $14.07 $391,125 - $628,929	44,700	44,700 $629,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.